InvestorsObserver is giving Abeona Therapeutics Inc (ABEO) an Analyst Rating Rank of 75, meaning ABEO is ranked higher by analysts than 75% of stocks. The average price target for ABEO is $5 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating ABEO a Strong Buy today. Find out what this means to you and get the rest of the rankings on ABEO!